Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1977 1
1979 1
1985 1
1986 1
1987 1
1989 1
1990 3
1991 4
1992 2
1993 1
1994 7
1995 5
1996 4
1997 3
1998 7
1999 5
2000 5
2001 4
2002 2
2003 5
2004 3
2005 6
2006 4
2007 7
2008 2
2009 5
2010 6
2011 8
2012 5
2013 9
2014 6
2015 5
2016 5
2017 9
2018 8
2019 5
2020 15
2021 14
2022 9
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Treatment for Livedoid Vasculopathy: A Systematic Review.
Micieli R, Alavi A. Micieli R, et al. JAMA Dermatol. 2018 Feb 1;154(2):193-202. doi: 10.1001/jamadermatol.2017.4374. JAMA Dermatol. 2018. PMID: 29141075
All of these therapies were associated with good clinical outcomes. Adverse events were observed in 44 patients (13%). CONCLUSIONS AND RELEVANCE: A variety of treatments with varying degrees of success have been used to treat livedoid vasculopathy. ...
All of these therapies were associated with good clinical outcomes. Adverse events were observed in 44 patients (13%). CONCLUSIONS AN …
Cryofibrinogenemia: What Rheumatologists Should Know.
Santiago MB, Melo BS. Santiago MB, et al. Curr Rheumatol Rev. 2022;18(3):186-194. doi: 10.2174/1573397118666220325110737. Curr Rheumatol Rev. 2022. PMID: 35339184 Review.
Cryofibrinogenemia is a rare disorder, clinically characterized by skin lesions, such as ulcers, necrosis, livedo reticularis, arthralgia, thrombosis, and limb ischemia. These features are most often observed in rheumatological practice and consist of differential d …
Cryofibrinogenemia is a rare disorder, clinically characterized by skin lesions, such as ulcers, necrosis, livedo reticularis, arthra …
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Cervera R, et al. Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24. Ann Rheum Dis. 2015. PMID: 24464962 Free article.
OBJECTIVES: To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later. METHODS: In 1999, we started an observationa …
OBJECTIVES: To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up …
Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides.
Frumholtz L, Laurent-Roussel S, Aumaître O, Maurier F, Le Guenno G, Carlotti A, Dallot A, Kemeny JL, Antunes L, Froment N, Fraitag S, London J, Berezne A, Terris B, Le Jeunne C, Mouthon L, Aractingi S, Guillevin L, Dupin N, Terrier B; French Vasculitis Study Group. Frumholtz L, et al. Autoimmun Rev. 2017 Nov;16(11):1138-1146. doi: 10.1016/j.autrev.2017.09.009. Epub 2017 Sep 14. Autoimmun Rev. 2017. PMID: 28918161 Review.
Lesions associated with MPA were segmentary edema (19.5% vs. 12.7% in EGPA and 4.3% in GPA) and livedo (12.4% vs. 0.5% and 2.6%, respectively), whereas those associated with EGPA were urticarial lesions (11.5% vs. 1.9% in GPA and 3.5% in MPA) and nodules (12,2% vs. 8.9% in …
Lesions associated with MPA were segmentary edema (19.5% vs. 12.7% in EGPA and 4.3% in GPA) and livedo (12.4% vs. 0.5% and 2.6%, resp …
Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
Nakashima C, Kato M, Otsuka A. Nakashima C, et al. J Dermatol. 2023 Mar;50(3):280-289. doi: 10.1111/1346-8138.16651. Epub 2023 Jan 13. J Dermatol. 2023. PMID: 36636825
., COVID toes), (ii) urticaria-like skin eruption, (iii) maculopapular lesions, (iv) vesicular eruptions, (v) purpura, (vi) livedo reticularis and necrotic lesions, (vii) urticarial vasculitis, and others such as alopecia and herpes zoster. The pathogenesis of skin eruptio …
., COVID toes), (ii) urticaria-like skin eruption, (iii) maculopapular lesions, (iv) vesicular eruptions, (v) purpura, (vi) livedo re …
Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.
Chasset F, Francès C. Chasset F, et al. Clin Rev Allergy Immunol. 2017 Dec;53(3):452-468. doi: 10.1007/s12016-017-8612-9. Clin Rev Allergy Immunol. 2017. PMID: 28547523 Review.
Dermatologic manifestations are observed in almost all systemic vasculitides, even in large-and medium-vessel vasculitides, although such vessels are not found in the skin. ...In the systemic subset, the most frequent skin lesions are in the order of frequency purpura, …
Dermatologic manifestations are observed in almost all systemic vasculitides, even in large-and medium-vessel vasculitides, although …
Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome.
Liu M, Li G, Song X, Fan Y, Li C. Liu M, et al. Sci Rep. 2023 Jun 1;13(1):8915. doi: 10.1038/s41598-023-35955-2. Sci Rep. 2023. PMID: 37264095 Free PMC article.
Patients with and without CNS involvement were compared regarding demographics and laboratory parameters. The analysis showed that older age, livedo reticularis, and dyslipidaemia were significant related factors for CNS manifestations (P = 0.047, 0.038, and 0.030 respecti …
Patients with and without CNS involvement were compared regarding demographics and laboratory parameters. The analysis showed that older age …
Cutis marmorata telangiectatica congenita: a literature review.
Bui TNPT, Corap A, Bygum A. Bui TNPT, et al. Orphanet J Rare Dis. 2019 Dec 4;14(1):283. doi: 10.1186/s13023-019-1229-8. Orphanet J Rare Dis. 2019. PMID: 31801575 Free PMC article. Review.
RESULTS: Of the identified patients, 24.5% had generalised CMTC, 66.8% had localised and 8.7% had a non-specified distribution of CMTC. Associated anomalies were observed in 42.5% of patients, predominantly body asymmetry and neurological defects like seizure and developme …
RESULTS: Of the identified patients, 24.5% had generalised CMTC, 66.8% had localised and 8.7% had a non-specified distribution of CMTC. Asso …
A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
Kolivras A, Thompson C, Pastushenko I, Mathieu M, Bruderer P, de Vicq M, Feoli F, Harag S, Meiers I, Olemans C, Sass U, Dehavay F, Fakih A, Lam-Hoai XL, Marneffe A, Van De Borne L, Vandersleyen V, Richert B. Kolivras A, et al. J Cutan Pathol. 2022 Jan;49(1):17-28. doi: 10.1111/cup.14099. Epub 2021 Aug 9. J Cutan Pathol. 2022. PMID: 34272741 Free PMC article. Review.
RESULTS: COVID-19-induced chilblains are clinically and histopathologically identical to chilblains from other causes. Although intravascular thrombi are sometimes observed, no patient had a systemic coagulopathy or severe clinical course. ...Patients presenting with acral …
RESULTS: COVID-19-induced chilblains are clinically and histopathologically identical to chilblains from other causes. Although intravascula …
Type I interferonopathies in pediatric rheumatology.
Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M. Volpi S, et al. Pediatr Rheumatol Online J. 2016 Jun 4;14(1):35. doi: 10.1186/s12969-016-0094-4. Pediatr Rheumatol Online J. 2016. PMID: 27260006 Free PMC article. Review.
Type I interferonopathies are a clinically heterogenic group of Mendelian diseases with a constitutive activation of this pathway that might present as atypical, severe, early onset rheumatic diseases. Skin vasculopathy with chilblains and livedo reticularis, interstitial …
Type I interferonopathies are a clinically heterogenic group of Mendelian diseases with a constitutive activation of this pathway that might …
190 results